Synonyms:Hyperoside, Hyperin, 482-36-0, Hyperosid, Quercetin 3-galactoside, Hyperozide, Quercetin-3-O-galactoside, Quercetin-3-galactoside, Quercetin 3-D-galactoside, Hyperasid, Jyperin, Quercetin 3-O-beta-D-galactopyranoside, Quercetin 3-beta-D-galactopyranoside, quercetin 3-O-galactoside, NSC 407304, CHEMBL251254, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one, CHEBI:67486, 8O1CR18L82, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one, Quercetin 3-.beta.-D-galactopyranoside, 2-(3,4-Dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one, Isoquercitrin, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(.beta.-D-galactopyranosyloxy)-5,7-dihydroxy-, quercetin galactoside, 2-[3,4-bis(oxidanyl)phenyl]-3-[(2S,3R,4S,5R,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5,7-bis(oxidanyl)chromen-4-one, QUERCETIN 3-B-D-GALACTOSIDE, MFCD00016933, UNII-8O1CR18L82, CCRIS 9339, p Hyperin, quercetin 3-O-beta-D-glucopyranoside, NSC-407304, Quercetin 3-O-.beta.-D-galactopyranoside, Hyperin,(S), EINECS 207-580-6, HYPEROSIDE [USP-RS], BIDD:PXR0057, 3,3',4',5,7-Pentahydroxyflavone 3-D-galactoside, MLS000759538, 2-yloxy)-4H-chromen-4-one, jm5b01461, Compound 84, MEGxp0_000392, SCHEMBL1250514, ACon1_000623, Quercetin 3-O-beta-D-galactoside, BDBM429266, DTXSID501028789, HMS2051H17, HY-N0452, quercetin 3-O--D-galactopyranoside, BDBM50241367, s5453, AKOS015896780, 6-(hydroxymethyl)tetrahydro-2H-pyran-, CCG-100970, NC00220, NCGC00168902-03, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one, AS-56199, SMR000466394, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, QUERCETIN 3-O-.BETA.-D-GALACTOSIDE, CS-0008982, Quercetin 3-D-galactoside, >=97.0% (HPLC), AB00639910-03, 3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-, Hyperoside, primary pharmaceutical reference standard, Q-100530, Q5242815, BRD-K84955386-001-01-1, 3-O-b-D-Galactopyranosyloxy-3',4',5,7-tetrahydroxyflavone, HYPEROSIDE (CONSTITUENT OF ST. JOHN'S WORT) [DSC], Hyperoside, United States Pharmacopeia (USP) Reference Standard, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl beta-D-galactopyranoside, 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl hexopyranoside #, 2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-chromen-4-one, 2-(3,4-DIHYDROXYPHENYL)-3-(.BETA.-D-GALACTOPYRANOSYLOXY)-5,7-DIHYDROXY-4H-1-BENZOPYRAN-4-ONE, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-4-one, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-, J6O
Pubchem:PUBCHEM:5281643
Id:79c53c7c-0ebe-5b3b-aaaa-22715fc9625e
Description:nan
